Nanomaterial Technology and Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is a malignant breast cancer subtype that is prone to progression, with high associated metastasis and five-year mortality rates and an overall poor prognosis. Chemotherapy is usually administered to treat TNBC without additional targeted therapies. Novel nanomat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Kai, Ning, Zeng, Chen, Hongbo, Wu, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790081/
https://www.ncbi.nlm.nih.gov/pubmed/35096628
http://dx.doi.org/10.3389/fonc.2021.828810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790081/
https://www.ncbi.nlm.nih.gov/pubmed/35096628
http://dx.doi.org/10.3389/fonc.2021.828810

Ejemplares similares